5 Articles found
Iktos Articles
-
Key points to succeed in Artificial Intelligence drug discovery projects
Abstract Drug discovery and development is an expensive, complex, and time-consuming task [5]. Recently, the development of artificial intelligence (AI) approaches to drug discovery, specifically de novo drug design through the use of deep ...
-
Integrating Synthetic Accessibility with AI-based Generative Drug Design
Abstract Generative models are frequently used for de novo design in drug discovery projects to propose new molecules. However, the question of whether or not the generated molecules can be synthesized is not systematically taken into account during ...
-
Tapping into the drug discovery potential of AI
Plentiful financing and multiple pharma partnerships illustrate the burgeoning interest in applying artificial intelligence tools to drug research and development. In April of this year, the German biotechnology company Evotec announced a phase 1 ...
-
Artificial Intelligence for New Drug Design
A Technology Platform for Deep-Learning-Based de novo Drug Design Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. Big data and artificial intelligence (AI) can ...
-
Artificial Intelligence for New Drug Design
Iktos Develops a Technology Platform for Deep Learning-Based de novo Drug Development Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. Big data and artificial ...